Cargando…

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Epidermal growth factor receptor (EGFR) has been shown to be over-expressed in TNBC and represents a rational treatment target. METHODS: We examined single agent and combinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canonici, Alexandra, Browne, Alacoque L., Ibrahim, Mohamed F. K., Fanning, Kevin P., Roche, Sandra, Conlon, Neil T., O’Neill, Fiona, Meiller, Justine, Cremona, Mattia, Morgan, Clare, Hennessy, Bryan T., Eustace, Alex J., Solca, Flavio, O’Donovan, Norma, Crown, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	TNBC in 2019: Promising Signals for the Treatment of a Formidable Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987485/ https://www.ncbi.nlm.nih.gov/pubmed/32064003 http://dx.doi.org/10.1177/1758835919897546

Ejemplares similares

Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
por: Simmons, Christine E., et al.
Publicado: (2020)

Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
por: Chan, Jack J., et al.
Publicado: (2019)

Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer
por: Knowlson, Catherine, et al.
Publicado: (2020)

Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
por: Fitzpatrick, Amanda, et al.
Publicado: (2019)

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

Novel antibody–drug conjugates for triple negative breast cancer
por: Nagayama, Aiko, et al.
Publicado: (2020)

A Systems Biology Approach to Investigate Kinase Signal Transduction Networks That Are Involved in Triple Negative Breast Cancer Resistance to Cisplatin
por: Mukherjee, Nupur, et al.
Publicado: (2022)

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
por: Eustace, Alex J, et al.
Publicado: (2008)

Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
por: Roche, Sandra, et al.
Publicado: (2023)

Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models
por: Santra, Tapesh, et al.
Publicado: (2017)

Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes
por: Pakharukova, Natalia, et al.
Publicado: (2021)

Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling
por: Abula, Yimamumaimaitijiang, et al.
Publicado: (2021)

Targeted treatment of advanced and metastaticbreast cancer with lapatinib
por: Corkery, Brendan, et al.
Publicado: (2008)

Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo
por: Maile, Laura A., et al.
Publicado: (2008)

Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy
por: Gaynor, Nicola, et al.
Publicado: (2023)

Syk and Src Family Kinases Regulate C-type Lectin Receptor 2 (CLEC-2)-mediated Clustering of Podoplanin and Platelet Adhesion to Lymphatic Endothelial Cells
por: Pollitt, Alice Y., et al.
Publicado: (2014)

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
por: McDermott, Martina, et al.
Publicado: (2014)

Hyperglycemia Enhances IGF-I–Stimulated Src Activation via Increasing Nox4-Derived Reactive Oxygen Species in a PKCζ-Dependent Manner in Vascular Smooth Muscle Cells
por: Xi, Gang, et al.
Publicado: (2012)

Alterations in integrin expression modulates invasion of pancreatic cancer cells
por: Walsh, Naomi, et al.
Publicado: (2009)

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
por: MAHGOUB, T., et al.
Publicado: (2015)

Annexin 2 Has a Dual Role as Regulator and Effector of v-Src in Cell Transformation
por: Hayes, Matthew J., et al.
Publicado: (2009)

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells
por: McDermott, Martina S. J., et al.
Publicado: (2019)

Personalised Medicine and the Economy of Biotechnological Promise
por: Sturdy, Steve
Publicado: (2017)

The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017)

Predictive biomarkers for dasatinib treatment in melanoma
por: Eustace, Alex J., et al.
Publicado: (2014)

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
por: Gaule, Patricia, et al.
Publicado: (2019)

Platelet Adhesion to Podoplanin Under Flow is Mediated by the Receptor CLEC-2 and Stabilised by Src/Syk-Dependent Platelet Signalling
por: Navarro-Núñez, Leyre, et al.
Publicado: (2015)

ERK Signals: Scaffolding Scaffolds?
por: Casar, Berta, et al.
Publicado: (2016)

Culturing primary neurons from rat hippocampus and cortex
por: Sahu, Madhusmita Priyadarshini, et al.
Publicado: (2019)

Cotinine inhibits TLR4/NF-κB signaling pathway and improves deep vein thrombosis in rats
por: Cheng, Zhiyuan, et al.
Publicado: (2020)

miR-26a-5p mediates TLR signaling pathway by targeting CTGF in LPS-induced alveolar macrophage
por: Li, Chunyan, et al.
Publicado: (2020)

Non-coding RNAs in neuropathic pain
por: Kalpachidou, Theodora, et al.
Publicado: (2020)

Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane
por: Katan, Matilda, et al.
Publicado: (2020)

TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling
por: Xiao, Yi, et al.
Publicado: (2020)

Extracellular microRNAs as messengers in the central and peripheral nervous system
por: Scott, Hannah
Publicado: (2017)

Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling
por: Wu, Haiyuan, et al.
Publicado: (2019)

Endoplasmic reticulum Ca(2+) release causes Rieske iron–sulfur protein-mediated mitochondrial ROS generation in pulmonary artery smooth muscle cells
por: Dong, Dapeng, et al.
Publicado: (2019)

Structural insights into the mechanism of oxidative activation of heme-free H-NOX from Vibrio cholerae
por: Mukhopadhyay, Roma, et al.
Publicado: (2020)

Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway
por: Ren, Zhouliang, et al.
Publicado: (2019)

π-Helix controls activity of oxygen-sensing diguanylate cyclases
por: Walker, Johnnie A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u4lesf18sevplnvbq989h6pfo8